Patient Investigational New Drug (sIND) applications in the United States SAN FRANCISCO, CA / ACCESS Newswire / September 30, ...
An FDA review of mifepristone is sparking concern over politics outweighing science, even as the agency approved a new ...
The anti-abortion movement’s patience with the Food and Drug Administration (FDA) is wearing thin following the agency’s ...
An Omaha mom says advocacy works after the Food and Drug Administration announced approval of a "lifesaving" drug her son is taking. It comes after two FDA denials this year.
Pharma companies are collaborating to boost the power of artificial intelligence (AI) in drug discovery by allowing access to ...
The drug will now be produced by Evita Solutions LLC, which describes its mission as being to ‘normalize abortion’ ...
Now that most abortions are chemical rather than surgical, pro-life advocates have amped up pressure on lawmakers and ...
Orphan drugs are therapeutics developed to address rare diseases typically defined by patient population thresholds that vary ...
The Trump administration announced Pfizer has agreed to provide all of its medicines at Most Favored Nation (MFN) pricing in ...
MedPage Today on MSNOpinion
Mifepristone Is Under Attack Again – With the Same Old Playbook
Twenty-five years ago, the FDA made a decision that changed the course of reproductive health in America. By approving ...
In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia ...
Illumina launches BioInsight, a new business to accelerate technology and data-driven discovery: San Diego Saturday, October 4, 2025, 14:00 Hrs [IST] Illumina, Inc., a global geno ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback